Schonfeld Strategic Advisors LLC Acquires 19,154 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Schonfeld Strategic Advisors LLC grew its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 357.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,511 shares of the company's stock after acquiring an additional 19,154 shares during the period. Schonfeld Strategic Advisors LLC's holdings in Henry Schein were worth $1,696,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Versant Capital Management Inc grew its stake in Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $32,000 after purchasing an additional 335 shares in the last quarter. Venturi Wealth Management LLC grew its stake in shares of Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock valued at $41,000 after buying an additional 569 shares in the last quarter. Quent Capital LLC increased its holdings in Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock worth $47,000 after buying an additional 323 shares during the last quarter. Smartleaf Asset Management LLC raised its position in Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after acquiring an additional 143 shares in the last quarter. Finally, City State Bank acquired a new stake in Henry Schein in the fourth quarter valued at $55,000. Institutional investors and hedge funds own 96.62% of the company's stock.

Analyst Upgrades and Downgrades

HSIC has been the topic of a number of research analyst reports. StockNews.com cut shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and raised their price objective for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Wells Fargo & Company assumed coverage on Henry Schein in a report on Friday, February 14th. They set an "equal weight" rating and a $80.00 target price on the stock. UBS Group cut their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Finally, Barrington Research reiterated an "outperform" rating and issued a $90.00 price objective on shares of Henry Schein in a report on Wednesday, February 26th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $80.20.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Henry Schein Trading Up 2.0 %

HSIC stock opened at $66.58 on Tuesday. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The company has a market capitalization of $8.16 billion, a PE ratio of 27.40, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. The company's 50-day simple moving average is $67.89 and its 200 day simple moving average is $71.55. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.11 by $0.04. The company had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business's revenue for the quarter was down .1% on a year-over-year basis. During the same period last year, the firm earned $1.10 earnings per share. As a group, sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.